ReviewCancer drug resistance (Alhambra, Calif.)2019

Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies.

Poornima Paramasivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.